Dr. Lapp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7421 Carmel Executive Park
Suite 320
Charlotte, NC 28226Phone+1 704-543-9692Fax+1 704-543-8547- Is this information wrong?
Education & Training
- University of North Carolina HospitalsResidency, Pediatrics, 1976 - 1977
- University of North Carolina HospitalsResidency, Internal Medicine, 1974 - 1976
- Albany Medical CollegeClass of 1974
Certifications & Licensure
- SC State Medical License 2016 - 2025
- NC State Medical License 1975 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Clinical Trials
- Ampligen in Chronic Fatigue Syndrome
- The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome Start of enrollment: 1998 Dec 01
Publications & Presentations
PubMed
- 25 citationsMulti-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort St...Elizabeth R. Unger, Jin-Mann S. Lin, Hao Tian, Benjamin H. Natelson, Gudrun Lange, Diana Vu, Michelle Blate, Nancy G. Klimas, Elizabeth Balbin, Lucinda Bateman, Ali Al...> ;American Journal of Epidemiology. 2017 Apr 15
- A framework for fibromyalgia management for primary care providers.Arnold LM, Clauw DJ, Dunegan LJ, Turk DC, FibroCollaborative> ;Mayo Clinic proceedings.
- 91 citationsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.Lucinda Bateman, Alison C. Bested, Hector Bonilla, Bela V. Chheda, Lily Chu, Jennifer M. Curtin, Tania T. Dempsey, Mary E. Dimmock, Theresa G. Dowell, Donna Felsenstei...> ;Mayo Clinic Proceedings. 2021 Nov 1
- Join now to see all
Journal Articles
- Managing Covid-19 Post Viral Fatigue SyndromeLapp C and J John, Fatigue: Biomedicine, Health & Behavior, 2/10/2021
Press Mentions
- Treatments Explored to Ease Postviral Symptoms of ME/CFS and Long COVIDAugust 8th, 2022
- AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Intranasal and an IV Therapy for Post-COVID-19 Cognitive Dysfunction (PCCD)August 25th, 2021
- AIM ImmunoTech : Company Presentation - March 2021March 11th, 2021
- Join now to see all
Industry Relationships
- Consultant / Thought Leader / Speaker, Pfizer2010 - 2015
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: